Thalys Medical Technology Group Corporation (SHA:603716)

China flag China · Delayed Price · Currency is CNY
21.15
+0.59 (2.87%)
May 19, 2026, 10:25 AM CST
Market Cap4.40B +144.9%
Revenue (ttm)971.32M -39.8%
Net Income-210.48M
EPS-1.04
Shares Out214.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,133,198
Average Volume10,697,736
Open20.75
Previous Close20.56
Day's Range20.75 - 22.00
52-Week Range10.80 - 38.12
Beta0.50
RSI37.34
Earnings DateApr 29, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Sector Healthcare
Founded 2004
Employees 1,246
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603716
Full Company Profile

Financial Performance

In 2025, SHA:603716's revenue was 1.08 billion, a decrease of -40.52% compared to the previous year's 1.81 billion. Losses were -207.28 million, -0.93% less than in 2024.

Financial Statements